CN111107848B - 一种含有酰胺类衍生物的药物组合物及其制备方法和应用 - Google Patents

一种含有酰胺类衍生物的药物组合物及其制备方法和应用 Download PDF

Info

Publication number
CN111107848B
CN111107848B CN201980004523.4A CN201980004523A CN111107848B CN 111107848 B CN111107848 B CN 111107848B CN 201980004523 A CN201980004523 A CN 201980004523A CN 111107848 B CN111107848 B CN 111107848B
Authority
CN
China
Prior art keywords
group
pharmaceutical composition
alkyl
pyridin
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980004523.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN111107848A (zh
Inventor
高鹏
孙广俊
王少宝
张福军
包如迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Shanghai Hansoh Biomedical Co Ltd
Original Assignee
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Shanghai Hansoh Biomedical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hansoh Pharmaceutical Group Co Ltd, Shanghai Hansoh Biomedical Co Ltd filed Critical Jiangsu Hansoh Pharmaceutical Group Co Ltd
Publication of CN111107848A publication Critical patent/CN111107848A/zh
Application granted granted Critical
Publication of CN111107848B publication Critical patent/CN111107848B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN201980004523.4A 2018-08-10 2019-08-09 一种含有酰胺类衍生物的药物组合物及其制备方法和应用 Active CN111107848B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2018109097922 2018-08-10
CN201810909792 2018-08-10
PCT/CN2019/099971 WO2020030107A1 (fr) 2018-08-10 2019-08-09 Composition pharmaceutique contenant des dérivés amides, son procédé de préparation et application associée

Publications (2)

Publication Number Publication Date
CN111107848A CN111107848A (zh) 2020-05-05
CN111107848B true CN111107848B (zh) 2023-05-23

Family

ID=69414002

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980004523.4A Active CN111107848B (zh) 2018-08-10 2019-08-09 一种含有酰胺类衍生物的药物组合物及其制备方法和应用

Country Status (3)

Country Link
CN (1) CN111107848B (fr)
TW (1) TW202012412A (fr)
WO (1) WO2020030107A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3825315B1 (fr) * 2018-07-20 2022-08-31 Fujian Akeylink Biotechnology Co., Ltd. Forme cristalline utilisée en tant qu'inhibiteur d'ask1, son procédé de préparation et son utilisation
CN110577533B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577534B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577540B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577537B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577538B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577535B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577536B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577541B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN110577539B (zh) * 2019-07-16 2021-07-23 广州安岩仁医药科技有限公司 苯甲酰氨基吡啶衍生物的盐及其在药物中的应用
CN113831323A (zh) * 2020-06-24 2021-12-24 武汉人福创新药物研发中心有限公司 芳杂环酰胺类化合物及其用途
CN115894404B (zh) * 2021-09-22 2024-07-16 杭州天玑济世生物科技有限公司 一类具有萘胺结构的小分子化合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI598347B (zh) * 2009-07-13 2017-09-11 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
UY35212A (es) * 2012-12-21 2014-06-30 Gilead Sciences Inc Inhibidores de la quinasa que regula la señal de la apoptosis
TW201618781A (zh) * 2014-08-13 2016-06-01 吉李德科學股份有限公司 治療肺高血壓之方法
US10787435B2 (en) * 2017-01-22 2020-09-29 Fuijan Cosunter Pharmaceutical Co. Ltd. ASK1 inhibitor and preparation method and use thereof
SG11201906579UA (en) * 2017-01-22 2019-08-27 Fujian Cosunter Pharmaceutical Co Ltd Pyridine derivative as ask1 inhibitor and preparation method and use thereof
WO2018151830A1 (fr) * 2017-02-17 2018-08-23 Fronthera U.S. Pharmaceuticals Llc Inhibiteurs de kinase de régulation du signal apoptotique à base de pyridinyle
TW201833108A (zh) * 2017-03-03 2018-09-16 大陸商江蘇豪森藥業集團有限公司 醯胺類衍生物抑制劑及其製備方法和應用
WO2018233553A1 (fr) * 2017-06-19 2018-12-27 广东东阳光药业有限公司 Composé bicyclique fusionné et son utilisation en médecine
CN109400625B (zh) * 2017-08-17 2021-11-12 广东东阳光药业有限公司 稠合双环类化合物及其在药物中的应用

Also Published As

Publication number Publication date
WO2020030107A1 (fr) 2020-02-13
TW202012412A (zh) 2020-04-01
CN111107848A (zh) 2020-05-05

Similar Documents

Publication Publication Date Title
CN111107848B (zh) 一种含有酰胺类衍生物的药物组合物及其制备方法和应用
CN109983007B (zh) 酰胺类衍生物抑制剂及其制备方法和应用
CN111295384B (zh) 双环类衍生物抑制剂、其制备方法和应用
TWI765908B (zh) 苯並咪唑類化合物激酶抑制劑及其製備方法和應用
CN115884969A (zh) 稠合咪唑类衍生物、其制备方法及其在医药上的应用
EP3919489A1 (fr) Composés cycliques aromatiques ou cycliques hétéroaromatiques, procédé de préparation correspondant et utilisation médicale associée
WO2021228173A1 (fr) Composés cycliques condensés du type azépine et utilisations médicales associées
CN113286796B (zh) 喜树碱衍生物及其水溶性前药、包含其的药物组合物及其制备方法和用途
CN114258393A (zh) 具有磷脂酰肌醇3-激酶δ和γ的双重抑制剂活性的杂环化合物及其医药用途
WO2024002376A1 (fr) Inhibiteurs de prmt5 et leur utilisation
CN113429440B (zh) 一种螺环化合物的前药、其制备方法及其在医药上的应用
WO2022237890A1 (fr) Composé à cycle fusionné du type azépine et son utilisation pharmaceutique
CN115884776B (zh) 杂环大环化合物及其医药用途
TWI768465B (zh) 四氫吲唑衍生物及其製備
CN117229295A (zh) 含氮大环类化合物及其制备方法和医药用途
WO2022166810A1 (fr) Dérivé azatricyclique condensé, son procédé de préparation et son utilisation en médecine
CN116589454A (zh) 芳香杂环类化合物及其制备方法和医药用途
CN116262749A (zh) 一类芳杂环取代的化合物及其制备方法和用途
TW202428279A (zh) 一種ｋｒａｓ ｇ１２ｄ抑制劑及其應用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant